BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thornton JR, Losowsky MS. Plasma beta endorphin in cirrhosis and renal failure. Gut 1991;32:306-8. [PMID: 2013426 DOI: 10.1136/gut.32.3.306] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Ong JP, Mullen KD. Hepatic encephalopathy. Eur J Gastroenterol Hepatol. 2001;13:325-334. [PMID: 11338058 DOI: 10.1097/00042737-200104000-00005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
2 Barreca T, Robaudo C, Cataldi A, Garibaldi A, Cianciosi P, Russo R, Rolandi E, Franceschini R. Plasma beta-endorphin levels and glucose tolerance in patients with chronic renal failure. Biomedicine & Pharmacotherapy 1995;49:283-7. [DOI: 10.1016/0753-3322(96)82644-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
3 Kozono H, Yoshitani H, Nakano R. Post-marketing surveillance study of the safety and efficacy of nalfurafine hydrochloride (Remitch® capsules 2.5 μg) in 3,762 hemodialysis patients with intractable pruritus. Int J Nephrol Renovasc Dis 2018;11:9-24. [PMID: 29391822 DOI: 10.2147/IJNRD.S145720] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
4 Wakasa Y, Fujiwara A, Umeuchi H, Endoh T, Okano K, Tanaka T, Nagase H. Inhibitory effects of TRK-820 on systemic skin scratching induced by morphine in rhesus monkeys. Life Sciences 2004;75:2947-57. [DOI: 10.1016/j.lfs.2004.05.033] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
5 Tajiri K, Shimizu Y. Recent advances in the management of pruritus in chronic liver diseases. World J Gastroenterol 2017; 23(19): 3418-3426 [PMID: 28596678 DOI: 10.3748/wjg.v23.i19.3418] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
6 Davis M. Cholestasis and endogenous opioids: liver disease and exogenous opioid pharmacokinetics. Clin Pharmacokinet 2007;46:825-50. [PMID: 17854233 DOI: 10.2165/00003088-200746100-00002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
7 Mattana J, Ahn J, Desroches L, Fitzmaurice S, Singhal PC. Naloxone-Responsive Encephalopathy in End-Stage Renal Disease. American Journal of Kidney Diseases 1993;21:669-72. [DOI: 10.1016/s0272-6386(12)80042-4] [Cited by in Crossref: 4] [Article Influence: 0.1] [Reference Citation Analysis]
8 Butelman ER, Reed B, Chait BT, Mandau M, Yuferov V, Kreek MJ. Limited effects of beta-endorphin compared to loperamide or fentanyl in a neuroendocrine biomarker assay in non-human primates. Psychoneuroendocrinology 2008;33:292-304. [PMID: 18171605 DOI: 10.1016/j.psyneuen.2007.11.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
9 Waele J, Audet RM, Rose C, Butterworth RF. The Portacaval-Shunted Rat: A New Model for the Study of the Mechanisms Controlling Voluntary Ethanol Consumption and Ethanol Preference? Alcoholism Clin Exp Res 1997;21:305-10. [DOI: 10.1111/j.1530-0277.1997.tb03765.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.0] [Reference Citation Analysis]
10 Campese VM. Pathophysiology of resistant hypertension in chronic kidney disease. Semin Nephrol. 2014;34:571-576. [PMID: 25416666 DOI: 10.1016/j.semnephrol.2014.08.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
11 Umeuchi H, Togashi Y, Honda T, Nakao K, Okano K, Tanaka T, Nagase H. Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system. Eur J Pharmacol. 2003;477:29-35. [PMID: 14512095 DOI: 10.1016/j.ejphar.2003.08.007] [Cited by in Crossref: 99] [Cited by in F6Publishing: 76] [Article Influence: 5.5] [Reference Citation Analysis]
12 Trelewicz P, Grzeszczak W, Drabczyk R. Serum beta-endorphin in non-dialysed and haemodialysed patients with chronic renal failure. International Urology and Nephrology 1994;26:117-23. [DOI: 10.1007/bf02768251] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]